Acquired Resistance of EGFR-Mutant Lung Cancer to a T790M-Specific EGFR Inhibitor: Emergence of a Third Mutation (C797S) in the EGFR Tyrosine Kinase Domain

被引：201
|
作者：
Yu, Helena A. [1 ,2 ]
Tian, Shaozhou K. [3 ]
Drilon, Alexander E. [1 ,2 ]
Borsu, Laetitia [3 ]
Riely, Gregory J. [1 ,2 ]
Arcila, Maria E. [3 ]
Ladanyi, Marc [3 ,4 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Thorac Oncol Serv, New York, NY 10021 USA
[2] Weill Cornell Med Coll, Dept Med, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10065 USA
[4] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA
来源：
JAMA ONCOLOGY | 2015年 / 1卷 / 07期
关键词：
MECHANISMS; REVEALS;
D O I：
10.1001/jamaoncol.2015.1066
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：981 / 983
页数：3
相关论文
共 50 条
  • [31] Characterization of EGFR T790M, L792F, and C797S Mutations as Mechanisms of Acquired Resistance to Afatinib in Lung Cancer
    Kobayashi, Yoshihisa
    Azuma, Koichi
    Nagai, Hiroki
    Kim, Young Hak
    Togashi, Yosuke
    Sesumi, Yuichi
    Chiba, Masato
    Shimoji, Masaki
    Sato, Katsuaki
    Tomizawa, Kenji
    Takemoto, Toshiki
    Nishio, Kazuto
    Mitsudomi, Tetsuya
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (02) : 357 - 364
  • [32] Local Therapy with Continued EGFR Tyrosine Kinase Inhibitor Therapy as a Treatment Strategy in EGFR-Mutant Advanced Lung Cancers That Have Developed Acquired Resistance to EGFR Tyrosine Kinase Inhibitors
    Yu, Helena A.
    Sima, Camelia S.
    Huang, James
    Solomon, Stephen B.
    Rimner, Andreas
    Paik, Paul
    Pietanza, M. Catherine
    Azzoli, Christopher G.
    Rizvi, Naiyer A.
    Krug, Lee M.
    Miller, Vincent A.
    Kris, Mark G.
    Riely, Gregory J.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (03) : 346 - 351
  • [33] Absence of EGFR C797S Mutation in Tyrosine Kinase Inhibitor-Naive Non-Small Cell Lung Cancer Tissues
    Oscorbin, Igor P.
    Shadrina, Alexandra S.
    Kozlov, Vadim V.
    Voitsitsky, Vladimir E.
    Filipenko, Maxim L.
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (02) : 1229 - 1234
  • [34] Dual Inhibition of EGFR with Afatinib and Cetuximab in Kinase Inhibitor-Resistant EGFR-Mutant Lung Cancer with and without T790M Mutations
    Janjigian, Yelena Y.
    Smit, Egbert F.
    Groen, Harry J. M.
    Horn, Leora
    Gettinger, Scott
    Camidge, D. Ross
    Riely, Gregory J.
    Wang, Bushi
    Fu, Yali
    Chand, Vikram K.
    Miller, Vincent A.
    Pao, William
    CANCER DISCOVERY, 2014, 4 (09) : 1036 - 1045
  • [35] Erlotinib and Trametinib in Patients With EGFR-Mutant Lung Adenocarcinoma and Acquired Resistance to a Prior Tyrosine Kinase Inhibitor
    Luo, Jia
    Makhnin, Alex
    Tobi, Yosef
    Ahn, Linda
    Hayes, Sara A.
    Iqbal, Afsheen
    Ng, Kenneth
    Arcila, Maria E.
    Riely, Gregory J.
    Kris, Mark G.
    Yu, Helena A.
    JCO PRECISION ONCOLOGY, 2021, 5 : 55 - 64
  • [36] The EGFR T790M Mutation in Acquired Resistance to an Irreversible Second-Generation EGFR Inhibitor
    Kim, Youngwook
    Ko, Jeonghun
    Cui, Zhengyun
    Abolhoda, Amir
    Lee, Jeeyun
    Ahn, Jinseok
    Ou, Sai-Hong
    Ahn, Myung-Ju
    Park, Keunchil
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S421 - S421
  • [37] The EGFR C797S Mutation Confers Resistance to a Novel EGFR Inhibitor CLN-081 to EGFR Exon 20 Insertion Mutations
    Kagawa, Yosuke
    Hayashida, Takuma
    Liu, Jie
    Mori, Shunta
    Izumi, Hiroki
    Kumagai, Shogo
    Udagawa, Hibiki
    Hattori, Noboru
    Goto, Koichi
    Kobayashi, Susumu S.
    JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (03):
  • [38] The EGFR T790M Mutation in Acquired Resistance to an Irreversible Second-Generation EGFR Inhibitor
    Kim, Youngwook
    Ko, Jeonghun
    Cui, ZhengYun
    Abolhoda, Amir
    Ahn, Jin Seok
    Ou, Sai-Hong
    Ahn, Myung-Ju
    Park, Keunchil
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (03) : 784 - 791
  • [39] Overcoming Resistance to Osimertinib by T790M Loss and C797S Acquisition Using Gefitinib in a Patient With EGFR-Mutant NSCLC: A Case Report
    Enrico, Diego
    Tsou, Florencia
    Catani, Greta
    Pupareli, Carmen
    Girotti, Maria Romina
    Alvarez, David Esteban Ulloa
    Waisberg, Federico
    Rodriguez, Andres
    Reyes, Roxana
    Chacon, Matias
    Reguart, Noemi
    Martin, Claudio
    JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (02):
  • [40] Recent updates on third generation EGFR inhibitors and emergence of fourth generation EGFR inhibitors to combat C797S resistance
    Patel, Harun
    Pawara, Rahul
    Ansari, Azim
    Surana, Sanjay
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 142 : 32 - 47
12345